Phathom Pharmaceuticals Inc (PHAT)
10.27
-0.13
(-1.25%)
USD |
NASDAQ |
Jun 28, 16:00
10.31
+0.04
(+0.39%)
After-Hours: 20:00
Phathom Pharmaceuticals Cash from Investing (Quarterly): -0.04M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.04M |
| December 31, 2023 | -0.475M |
| September 30, 2023 | -0.939M |
| June 30, 2023 | -0.006M |
| March 31, 2023 | -0.214M |
| December 31, 2022 | -0.412M |
| September 30, 2022 | -0.134M |
| June 30, 2022 | -0.428M |
| March 31, 2022 | -0.067M |
| December 31, 2021 | -0.10M |
| September 30, 2021 | -0.014M |
| Date | Value |
|---|---|
| June 30, 2021 | -0.045M |
| March 31, 2021 | -0.169M |
| December 31, 2020 | -0.124M |
| September 30, 2020 | -0.183M |
| June 30, 2020 | -0.057M |
| March 31, 2020 | -0.676M |
| December 31, 2019 | -0.106M |
| September 30, 2019 | -0.026M |
| June 30, 2019 | -25.12M |
| March 31, 2019 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-25.12M
Minimum
Jun 2019
-0.006M
Maximum
Jun 2023
-1.467M
Average
-0.129M
Median
Cash from Investing (Quarterly) Benchmarks
| Insmed Inc | 295.32M |
| Regeneron Pharmaceuticals Inc | -1.687B |
| Rocket Pharmaceuticals Inc | 35.03M |
| Rhythm Pharmaceuticals Inc | 30.05M |
| Biomea Fusion Inc | -0.035M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -69.02M |
| Cash from Financing (Quarterly) | 9.90M |
| Free Cash Flow | -168.39M |
| Free Cash Flow Per Share (Quarterly) | -1.183 |
| Free Cash Flow to Equity (Quarterly) | -80.24M |
| Free Cash Flow Yield | -29.67% |